Literature DB >> 19020880

Oncological risk of laparoscopic surgery in urothelial carcinomas.

Morgan Rouprêt1, Gordon Smyth, Jacques Irani, Laurent Guy, Jean-Louis Davin, Fabien Saint, Christian Pfister, Hervé Wallerand, François Rozet.   

Abstract

OBJECTIVE: To assess the oncological safety of laparoscopic procedures for the management of urothelial carcinomas of the urinary tract.
METHODS: Data on laparoscopic management of urothelial carcinomas in the literature were analysed using MEDLINE and by matching the following keywords: urological malignancies, upper tract tumours, bladder carcinomas, laparoscopic approach, recurrence, follow-up and metastasis site.
RESULTS: Minimally invasive techniques are being used increasingly in the management of these tumours and successfully achieving the benefits of lower blood loss and more rapid patient recovery. To date, no evidence level 1 information is available and published series of these technically challenging cases are small and follow-up limited. Short to medium term follow-up appears encouraging in terms of recurrence and survival rates, but long-term data are immature compared to the established open techniques these procedures seek to duplicate. Specific concerns in terms of the oncologic safety of laparoscopy, especially with regard to the pneumoperitoneum, tumour manipulation and specimen extraction are addressed. Port-site metastases and tumour seeding are rare events and appear to be mainly related to the grade and stage of the tumour. Specific precautions are required to minimise these risks.
CONCLUSION: Oncological results of the laparoscopic approach are difficult to compare with those of open surgery. However, recent series have not reported unusual tumour dissemination or a higher rate of recurrence with this approach. Laparoscopic techniques are not yet standard of care in invasive urothelial carcinomas. Long-term assessment is ongoing and awaited.

Entities:  

Mesh:

Year:  2008        PMID: 19020880     DOI: 10.1007/s00345-008-0349-x

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  64 in total

1.  Port site metastasis after laparoscopic nephro-ureterectomy for transitional cell carcinoma.

Authors:  N Naderi; J A Nieuwenhuijzen; A Bex; A Kooistra; S Horenblas
Journal:  Eur Urol       Date:  2004-10       Impact factor: 20.096

2.  Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: comparison of laparoscopic and open surgery.

Authors:  Masao Tsujihata; Norio Nonomura; Akira Tsujimura; Kazuhiro Yoshimura; Yasushi Miyagawa; Akihiko Okuyama
Journal:  Eur Urol       Date:  2005-12-20       Impact factor: 20.096

Review 3.  Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches.

Authors:  Athanasios N Argyropoulos; David A Tolley
Journal:  BJU Int       Date:  2007-05       Impact factor: 5.588

4.  Laparoscopic nephroureterectomy: initial clinical case report.

Authors:  R V Clayman; L R Kavoussi; R S Figenshau; P S Chandhoke; D M Albala
Journal:  J Laparoendosc Surg       Date:  1991-12

5.  Laparoscopic nephroureterectomy for transitional cell carcinoma of renal pelvis and ureter: Nagoya experience.

Authors:  Ryohei Hattori; Yasushi Yoshino; Momokazu Gotoh; Masashi Katoh; Osamu Kamihira; Yoshinari Ono
Journal:  Urology       Date:  2006-03-29       Impact factor: 2.649

6.  Laparoscopic assisted radical cystectomy: the montsouris experience after 84 cases.

Authors:  Xavier Cathelineau; Carlos Arroyo; François Rozet; Eric Barret; Guy Vallancien
Journal:  Eur Urol       Date:  2005-04-11       Impact factor: 20.096

7.  Port site metastases after robot-assisted laparoscopic radical cystectomy.

Authors:  Nasr A El-Tabey; Ahmed M Shoma
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

8.  Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.

Authors:  Morgan Rouprêt; Vincent Hupertan; Olivier Traxer; Guillaume Loison; Emmanuel Chartier-Kastler; Pierre Conort; Marc-Olivier Bitker; Bernard Gattegno; François Richard; Olivier Cussenot
Journal:  Urology       Date:  2006-06       Impact factor: 2.649

9.  Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma.

Authors:  M J Scolieri; M L Paik; S L Brown; M I Resnick
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

10.  Open versus laparoscopy-assisted radical cystectomy: results of a prospective study.

Authors:  Francesco Porpiglia; Julien Renard; Michele Billia; Cesare Scoffone; Cecilia Cracco; Carlo Terrone; Roberto Mario Scarpa
Journal:  J Endourol       Date:  2007-03       Impact factor: 2.942

View more
  15 in total

1.  Early immune outcome of retroperitoneal laparoscopic radical nephrectomy for localized renal cell carcinoma: a prospective, randomized study.

Authors:  Yang Lu; Fan Tianyong; Wei Qiang; Cui Xiaobo; Bu Siyuan; Han Ping
Journal:  Can Urol Assoc J       Date:  2011-11-02       Impact factor: 1.862

Review 2.  Predictive factors of recurrence and survival of upper tract urothelial carcinomas.

Authors:  Grégory Verhoest; Shahrokh F Shariat; Thomas F Chromecki; Jay D Raman; Vitaly Margulis; Giacomo Novara; Christian Seitz; Mesut Remzi; Morgan Rouprêt; Douglas S Scherr; Karim Bensalah
Journal:  World J Urol       Date:  2011-06-17       Impact factor: 4.226

3.  The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology.

Authors:  Simone Albisinni; Marco Oderda; Laurent Fossion; Virginia Varca; Jens Rassweiler; Xavier Cathelineau; Piotr Chlosta; Alexandre De la Taille; Franco Gaboardi; Thierry Piechaud; Peter Rimington; Laurent Salomon; Rafael Sanchez-Salas; Jens-Uwe Stolzenburg; Dogu Teber; Roland Van Velthoven
Journal:  World J Urol       Date:  2015-07-02       Impact factor: 4.226

Review 4.  Current role of lymphadenectomy in the upper tract urothelial carcinoma.

Authors:  Mario Alvarez-Maestro; Juan Gómez Rivas; Sergio Alonso Y Gregorio; Cristina de Castro Guerin; Ángel Tabernero Gómez; Jesús Cisneros Ledo
Journal:  Cent European J Urol       Date:  2016-11-30

5.  Transient variations in the serum concentrations of cell adhesion molecules following retroperitoneal laparoscopic and open radical nephrectomy for localized renal-cell carcinoma.

Authors:  Lu Yang; Tianyong Fan; Qiang Wei; Xiaobo Cui; Siyuan Bu; Ping Han
Journal:  J Endourol       Date:  2012-08-20       Impact factor: 2.942

6.  Hand-assisted laparoscopic bladder cuff excision via the same hand port as that used for nephroureterectomy.

Authors:  Geehyun Song; Kyung-Sik Han; Sang Hoon Song; Myung-Soo Choo; Hanjong Ahn; Bumsik Hong
Journal:  World J Urol       Date:  2015-01-24       Impact factor: 4.226

Review 7.  Oncologic outcomes obtained after laparoscopic, robotic and/or single port nephroureterectomy for upper urinary tract tumours.

Authors:  Maria J Ribal; J Huguet; A Alcaraz
Journal:  World J Urol       Date:  2012-10-25       Impact factor: 4.226

8.  Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.

Authors:  Hyung Suk Kim; Ja Hyeon Ku; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim
Journal:  World J Urol       Date:  2015-10-23       Impact factor: 4.226

9.  Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.

Authors:  Jian-Ye Liu; Ying-Bo Dai; Fang-Jian Zhou; Zhi Long; Yong-Hong Li; Dan Xie; Bin Liu; Jin Tang; Jing Tan; Kun Yao; Le-Ye He
Journal:  BMC Surg       Date:  2017-01-17       Impact factor: 2.102

10.  Comparison of laparoscopic, hand-assisted, and open surgical nephroureterectomy.

Authors:  Hiroshi Kitamura; Toshihiro Maeda; Toshiaki Tanaka; Fumimasa Fukuta; Ko Kobayashi; Naotaka Nishiyama; Satoshi Takahashi; Naoya Masumori
Journal:  JSLS       Date:  2014 Apr-Jun       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.